REFERENCES
- Levey AS, Beto JA, Coronado BE, . Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32:853–906.
- Weiner DE, Tighiouart H, Stark PC, . Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198–206.
- Mark JS. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2004;41(S5):S11–S17.
- Parfrey PS. Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant. 2000;15:58–68.
- Chertow GM, Normand S-LT, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis. 2000;35:1044–1051.
- Herzog CA. Poor long-term survival of dialysis patients after acute myocardial infarction: Bad treatment or bad disease? Am J Kidney Dis. 2000;35:1217–1220.
- Hemmelgarn BR, Ghali WA, Quan H, . Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis. 2001;37:64–72.
- Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 2001;37:1191–1200.
- Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799–805.
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl. 3):112–119.
- Mallamaci F, Zoccali C, Tripepi G, . CREED investigators: The cardiovascular risk extended evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001;59:1559–1566.
- Adeera L, Ognjenka K, Brendan B, . Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kidney Dis. 2001;38:1398–1407.
- Schiller NB, Shah PM, Crawford M, . Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Am Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367.
- Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072–1083.
- Devereux RB, Alonso DR, Lutas EM, . Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
- Moon KH, Song IS, Yang WS, . Hypoalbuminemia as a risk factor for progressive left ventricular hypertrophy in hemodialysis patients. Am J Nephrol. 2000;20:396–401.
- Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7:728–736.
- Harty J, Venning M, Gokal R. Does CAPD guarantee adequate dialysis delivery and nutrition? Nephrol Dial Transplant. 1994;9:1721–1723.
- Rocco MV, Yan G, Gassman J, . Hemodialysis Study Group. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. Am J Kidney Dis. 2002;39:146–153.
- Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32:830–835.
- Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61.